Opinion

Video

Applying NCCN Guidelines in the Treatment of mBC

Britny Brown, PharmD, BCOP, discusses the importance of the NCCN guidelines in the treatment of metastatic breast cancer (mBC) and explains how the NCCN recommendations for CDK4/6 inhibitors differ for first-line patients.

Related Videos
3 KOLs are featured in this series.
3 KOLs are featured in this series.
3 KOLs are featured in this series.
3 KOLs are featured in this series.
3 KOLs are featured in this series.
1 KOL is featured in this series.
1 KOL is featured in this series.
3 KOLs are featured in this series.
3 KOLs are featured in this series.
3 KOLs are featured in this series.
Related Content
Breast cancer awareness -- Image credit: Siam | stock.adobe.com
November 22nd 2024

NCCN Announces Expanded Practice Guidelines for Breast Cancer With Hereditary Risks

Gillian McGovern, Assistant Editor
Pharmacy Focus: Oncology Edition- Exploring Pelareorep: A Novel Immunotherapy for Advanced Breast Cancer
October 28th 2024

Pharmacy Focus: Oncology Edition- Exploring Pelareorep: A Novel Immunotherapy for Advanced Breast Cancer

Patient with breast cancer -- Image credit: Keopaserth | stock.adobe.com
November 8th 2024

Web-Based Interventions Effective in Improving Quality of Life for Patients With Breast Cancer

Gillian McGovern, Assistant Editor
Pharmacy Focus- Oncology Edition: Delayed Breast Cancer Screenings
August 29th 2024

Pharmacy Focus- Oncology Edition: Delayed Breast Cancer Screenings

X-ray of tumor in breast -- Image credit: Sebastian Kaulitzki | stock.adobe.com
November 5th 2024

Study Finds Behaviors of Breast Cancer Cells Help Predict Risk of Bone Metastasis

Gillian McGovern, Assistant Editor
Social Determinants of Health Matter When Treating Patients With Breast Cancer
November 4th 2024

Social Determinants of Health Matter When Treating Patients With Breast Cancer

Maria Roberts, PharmD Angie Oster, PharmD Michelle Brisco Fields, PharmD, MBA, MHA Cara Colodonato, PharmD Jay Koirala